Johns Hopkins Medicine International Board Members
Christopher W. Kersey, M.D., M.B.A. (Chairman)
Christopher W. Kersey serves as a Managing Member of Camden Partners of Baltimore, Maryland, where he focuses on private equity investments in the health care and life science industries. Founded in 1995, Camden Partners is one of the largest growth equity and investment management funds in the United States with more than $700 million under management.
Dr. Kersey serves on the board of directors of Community Education Centers (CEC) Inc., Essence Group Holdings Corporation, Implantable Provider Group (IPG) Inc., PatientSafe Solutions Inc., Santa Rosa Holdings Corporation and Scribes STAT Inc. Dr. Kersey’s previous portfolio companies include MedServe Inc. (acquired by Stericycle Corporation, NASDAQ: SRCL), AlgoRx Pharmaceuticals Inc. (acquired by Anesiva Corporation, NASDAQ: ANSV), LipoScience Corporation (NASDAQ: LPDX), MacroGenics Corporation (NASDAQ: MGNX), Medivance Inc. (acquired by C.R. Bard Corporation, NYSE: BCR), Pet DRx Inc. (acquired by VCA Antech Corporation, NASDAQ: WOOF), Rejuvenon Inc. (acquired by Helsinn Healthcare S.A.), Targacept Corporation (NASDAQ: TRGT), Webmedx Inc. (acquired by Nuance Communications, NASDAQ: NUAN) and Xeotron Corporation (acquired by Life Technologies Corporation, NASDAQ: LIFE).
Dr. Kersey serves on the board of trustees of Johns Hopkins Medicine and the board of trustees of The Johns Hopkins Hospital, the #1 ranked hospital in the country according to the U.S. News & World Report annual rankings of American hospitals. Dr. Kersey serves on the board of directors of The Johns Hopkins Hospital Endowment Fund, and he is the Chairman of the Board of Johns Hopkins Medicine International, the global development arm of Johns Hopkins Medicine with hospital management and clinical education services in the Middle East, North America, South America, Europe and Asia.
Dr. Kersey’s international experience includes work with Sumitomo Biosciences in Japan and the World Bank in the former Soviet Union (the Republic of Georgia) as well as research fellowships focusing on the National Health Service in the United Kingdom and Sweden-based Telefon LM AB Ericsson's market entry into China.
A Phi Beta Kappa, Truman Scholar and Presidential Scholar graduate of Stanford University, Dr. Kersey graduated summa cum laude as the Class of 1996 Valedictorian at the Emory University School of Medicine. In 1996, Dr. Kersey attained the distinction of becoming one of the first individuals in history to be accepted in the same year into the residency program of Harvard Medical School as well as Harvard Law School and Harvard Business School, where he later graduated as the Class of 1998 Walter Fellow as one of the school’s first medical doctors.